XML 67 R56.htm IDEA: XBRL DOCUMENT v3.24.1
Condensed Parent Company Financial Statements (Tables)
12 Months Ended
Dec. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
Balance sheet

BALANCE SHEETS

 

 

 

 

 

 

(Dollars in thousands)

 

December 31, 2023

 

 

December 31, 2022

 

ASSETS

 

 

 

Cash and due from banks

 

$

251

 

 

$

1,807

 

Investment securities

 

 

63

 

 

 

63

 

Investments in subsidiaries

 

 

155,409

 

 

 

134,068

 

Other assets

 

 

803

 

 

 

941

 

Total assets

 

$

156,526

 

 

$

136,879

 

 

 

 

 

 

 

LIABILITIES & SHAREHOLDERS' EQUITY

 

 

 

 

 

 

Junior subordinated debt

 

$

3,459

 

 

$

3,413

 

Other liabilities

 

 

27

 

 

 

50

 

Stockholders' equity

 

 

153,040

 

 

 

133,416

 

Total liabilities and stockholders' equity

 

$

156,526

 

 

$

136,879

 

Statement of income

STATEMENTS OF INCOME

 

 

 

 

 

 

(Dollars in thousands)

 

For the years ended

 

 

 

December 31, 2023

 

 

December 31, 2022

 

 

 

 

 

Dividends from subsidiary

 

$

6,000

 

 

$

7,500

 

Net interest expense

 

 

(309

)

 

 

(190

)

Noninterest income

 

 

463

 

 

 

-

 

Noninterest expense

 

 

1,375

 

 

 

1,418

 

Income before income taxes

 

$

4,779

 

 

$

5,892

 

Income tax (benefit)

 

 

(233

)

 

 

(313

)

Income before equity in undistributed earnings of
   subsidiaries

 

$

5,012

 

 

$

6,205

 

Equity in undistributed earnings of subsidiaries

 

 

14,251

 

 

 

17,233

 

Net income

 

$

19,263

 

 

$

23,438

 

Statement of cash flow

STATEMENTS OF CASH FLOWS

 

 

 

 

 

 

(Dollars in thousands)

 

For the years ended

 

 

 

December 31, 2023

 

 

December 31, 2022

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

Net income

 

$

19,263

 

 

$

23,438

 

Adjustments to reconcile net income to net cash
   provided by operating activities:

 

 

 

 

 

 

Equity in undistributed earnings of subsidiaries

 

 

(14,251

)

 

 

(17,233

)

Net accretion of certain acquisition-related adjustments

 

 

46

 

 

 

46

 

Amortization

 

 

-

 

 

 

55

 

Deferred tax expense (benefit)

 

 

(275

)

 

 

298

 

Stock option & restricted stock grant expense

 

 

727

 

 

 

687

 

Increase (decrease) in other assets

 

 

138

 

 

 

(140

)

Decrease in other liabilities

 

 

(23

)

 

 

(392

)

Net cash provided by operating activities

 

$

5,625

 

 

$

6,759

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

Gain on termination of swap

 

 

460

 

 

 

-

 

Liquidation of swap collateral

 

 

(585

)

 

 

-

 

Proceeds from stock options exercised

 

 

18

 

 

 

23

 

Dividends paid

 

 

(7,074

)

 

 

(6,392

)

Net cash used in financing activities

 

$

(7,181

)

 

$

(6,369

)

 

 

 

 

 

 

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

 

 

(1,556

)

 

 

390

 

 

 

 

 

 

 

CASH AND CASH EQUIVALENTS

 

 

 

 

 

 

Beginning of period

 

 

1,807

 

 

 

1,417

 

End of period

 

$

251

 

 

$

1,807